Financials in USD. Standardized financial statements.
A compact view of how Microbix Biosystems Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $18.61M | $25.39M | $16.51M | $19.08M | $18.59M | $10.52M | $13.41M | $12.51M | $10.19M | $9.52M |
| Revenue Growth? | -26.7% | +53.8% | -13.4% | +2.6% | +76.7% | -21.5% | +7.2% | +22.8% | +7.0% | 0.0% |
| Cost of Revenue? | $8.74M | $10.00M | $9.03M | $7.95M | $7.55M | $5.86M | $6.86M | $7.14M | $5.37M | $4.54M |
| Gross Profit? | $9.87M | $15.39M | $7.48M | $11.12M | $11.04M | $4.66M | $6.55M | $5.37M | $4.81M | $4.98M |
| Gross Margin? | +53.0% | +60.6% | +45.3% | +58.3% | +59.4% | +44.3% | +48.8% | +42.9% | +47.2% | +52.3% |
| Operating Expenses? | $11.45M | $11.49M | $10.22M | $8.51M | $6.21M | $5.19M | $5.44M | $5.26M | $5.39M | $4.14M |
| Operating Income? | -$1.58M | $3.91M | -$2.74M | $2.69M | $4.84M | -$524,601 | $1.11M | -$742,808 | -$1.50M | $148,407 |
| EBITDA? | $203,491 | $6.21M | $1.96M | $3.33M | $5.66M | -$2.91M | $1.68M | -$7.08M | -$2.80M | $1.25M |
| Income Before Tax | -$2.30M | $3.67M | -$39,483 | $1.87M | $3.23M | -$4.66M | $43,681 | -$8.62M | -$4.23M | $148,407 |
| Income Tax Expense | -$55,726 | $150,563 | $0 | $77,234 | $0 | $1.57M | $11,763 | $0 | -$450,000 | -$600,000 |
| Net Income? | -$2.25M | $3.52M | -$39,483 | $1.79M | $1.63M | -$6.23M | $31,918 | -$8.62M | -$3.78M | $748,407 |
| EPS? | $-0.02 | $0.03 | $-0.00 | $0.01 | $0.01 | $-0.06 | $0.00 | $-0.09 | $-0.04 | $0.01 |
| Diluted EPS? | $-0.02 | $0.03 | $-0.00 | $0.01 | $0.01 | $-0.06 | $0.00 | $-0.09 | $-0.04 | $0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality